Pinnacle Associates LTD Macrogenics Inc Transaction History

Pinnacle Associates LTD

  • $7.15 Billion
  • Q3 2025

A detailed history of Pinnacle Associates LTD transactions in Macrogenics Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 338,106 shares of MGNX stock, worth $520,683. This represents 0.01% of its overall portfolio holdings.

Number of Shares
338,106
Previous 350,967 3.66%
Holding current value
$520,683
Previous $424,000 35.38%
% of portfolio
0.01%
Previous 0.01%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$1.29 - $2.1 $16,590 - $27,008
-12,861 Reduced 3.66%
338,106 $574,000
Q2 2025

Aug 04, 2025
SELL
$1.06 - $1.79 $133,060 - $224,696
-125,529 Reduced 26.34%
350,967 $424,000
Q1 2025

May 06, 2025
SELL
$1.26 - $3.49 $31,946 - $88,485
-25,354 Reduced 5.05%
476,496 $605,000
Q4 2024

Feb 14, 2025
SELL
$3.18 - $4.46 $591,893 - $830,139
-186,130 Reduced 27.05%
501,850 $1.63 Million
Q3 2024

Oct 25, 2024
BUY
$3.0 - $5.55 $151,983 - $281,168
50,661 Added 7.95%
687,980 $2.26 Million
Q2 2024

Jul 30, 2024
SELL
$3.31 - $18.51 $32,821 - $183,545
-9,916 Reduced 1.53%
637,319 $2.71 Million
Q1 2024

Apr 26, 2024
SELL
$9.77 - $21.47 $398,078 - $874,795
-40,745 Reduced 5.92%
647,235 $9.53 Million
Q4 2023

Jan 19, 2024
SELL
$4.48 - $10.11 $40,709 - $91,869
-9,087 Reduced 1.3%
687,980 $6.62 Million
Q3 2023

Oct 23, 2023
SELL
$4.48 - $6.19 $57,505 - $79,454
-12,836 Reduced 1.81%
697,067 $3.25 Million
Q2 2023

Jul 26, 2023
BUY
$4.62 - $7.54 $1.55 Million - $2.54 Million
336,430 Added 90.08%
709,903 $3.8 Million
Q1 2023

May 04, 2023
BUY
$4.82 - $7.24 $33,079 - $49,688
6,863 Added 1.87%
373,473 $2.68 Million
Q4 2022

Jan 31, 2023
SELL
$3.34 - $6.98 $2,999 - $6,268
-898 Reduced 0.24%
366,610 $2.46 Million
Q4 2022

Jan 25, 2023
SELL
$3.34 - $6.98 $167,066 - $349,139
-50,020 Reduced 11.98%
367,508 $0
Q3 2022

Oct 31, 2022
BUY
$3.01 - $5.22 $69,558 - $120,628
23,109 Added 5.86%
417,528 $1.45 Million
Q2 2022

Aug 02, 2022
SELL
$2.25 - $9.99 $20,693 - $91,878
-9,197 Reduced 2.28%
394,419 $1.16 Million
Q1 2022

May 05, 2022
SELL
$8.12 - $16.9 $119,972 - $249,697
-14,775 Reduced 3.53%
403,616 $3.56 Million
Q4 2021

Feb 02, 2022
BUY
$15.91 - $21.88 $29,163 - $40,106
1,833 Added 0.44%
418,391 $6.72 Million
Q3 2021

Oct 19, 2021
SELL
$19.74 - $28.7 $113,208 - $164,594
-5,735 Reduced 1.36%
416,558 $8.72 Million
Q2 2021

Aug 02, 2021
BUY
$20.49 - $35.63 $110,379 - $191,938
5,387 Added 1.29%
422,293 $11.3 Million
Q1 2021

May 12, 2021
BUY
$18.99 - $33.2 $1.43 Million - $2.49 Million
75,060 Added 21.96%
416,906 $13.3 Million
Q4 2020

Jan 26, 2021
SELL
$19.41 - $26.0 $1.66 Million - $2.22 Million
-85,550 Reduced 20.02%
341,846 $7.82 Million
Q3 2020

Oct 23, 2020
SELL
$24.69 - $31.6 $2.37 Million - $3.03 Million
-95,910 Reduced 18.33%
427,396 $10.8 Million
Q2 2020

Aug 14, 2020
SELL
$5.2 - $29.12 $1.24 Million - $6.96 Million
-239,064 Reduced 31.36%
523,306 $14.6 Million
Q1 2020

May 13, 2020
SELL
$4.28 - $12.11 $413,341 - $1.17 Million
-96,575 Reduced 11.24%
762,370 $4.44 Million
Q4 2019

Feb 03, 2020
BUY
$7.95 - $12.27 $2.44 Million - $3.77 Million
306,865 Added 55.58%
858,945 $9.35 Million
Q3 2019

Nov 08, 2019
SELL
$12.44 - $17.48 $303,349 - $426,249
-24,385 Reduced 4.23%
552,080 $7.05 Million
Q2 2019

Aug 05, 2019
SELL
$14.51 - $19.71 $706,390 - $959,541
-48,683 Reduced 7.79%
576,465 $9.78 Million
Q1 2019

May 10, 2019
BUY
$11.11 - $25.6 $965,681 - $2.23 Million
86,920 Added 16.15%
625,148 $11.2 Million
Q4 2018

Feb 05, 2019
SELL
$11.75 - $21.42 $658,799 - $1.2 Million
-56,068 Reduced 9.43%
538,228 $6.84 Million
Q3 2018

Nov 13, 2018
SELL
$19.26 - $23.46 $1.69 Million - $2.06 Million
-87,644 Reduced 12.85%
594,296 $12.7 Million
Q2 2018

Aug 08, 2018
SELL
$19.78 - $24.67 $2.14 Million - $2.67 Million
-108,160 Reduced 13.69%
681,940 $14.1 Million
Q1 2018

May 11, 2018
SELL
$18.89 - $32.46 $507,668 - $872,362
-26,875 Reduced 3.29%
790,100 $19.9 Million
Q4 2017

Feb 12, 2018
SELL
$16.19 - $20.3 $424,178 - $531,860
-26,200 Reduced 3.11%
816,975 $15.5 Million
Q3 2017

Nov 13, 2017
BUY
$15.52 - $18.94 $3.63 Million - $4.43 Million
233,657 Added 38.33%
843,175 $15.6 Million
Q2 2017

Aug 09, 2017
BUY
N/A
609,518
609,518 $10.7 Million

Others Institutions Holding MGNX

# of Institutions
111
Shares Held
50M
Call Options Held
65.5K
Put Options Held
93.9K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $94.6M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email